Literature DB >> 33310706

Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 33310706     DOI： 10.1136/bmj.m4826

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

1.  Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach.

Authors:  Fouad Trad; Salah El Falou
Journal:  SN Comput Sci       Date:  2022-05-25

Review 2.  Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis.

Authors:  Federico Vittorio Rossi; Dario Gentili; Enrico Marcantoni
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

3.  What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments.

Authors:  Dominik Wawrzuta; Mariusz Jaworski; Joanna Gotlib; Mariusz Panczyk
Journal:  Vaccines (Basel)       Date:  2021-05-10

4.  Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2).

Authors:  Werner Leber; Oliver Lammel; Andrea Siebenhofer; Monika Redlberger-Fritz; Jasmina Panovska-Griffiths; Thomas Czypionka
Journal:  EClinicalMedicine       Date:  2021-07-13

Review 5.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

6.  Development and Psychometric Properties of the Health Belief Scales Toward COVID-19 Vaccine in Ho Chi Minh City, Vietnam.

Authors:  Giao Huynh; Han Thi Ngoc Nguyen; Vien Truong Nguyen; An Le Pham
Journal:  Risk Manag Healthc Policy       Date:  2021-06-16

Review 7.  COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform.

Authors:  Muhammad Umer Ashraf; Yeji Kim; Sunil Kumar; Dongyeob Seo; Maryam Ashraf; Yong-Soo Bae
Journal:  Vaccines (Basel)       Date:  2021-02-18

8.  Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan.

Authors:  Tomohiro Ishimaru; Makoto Okawara; Hajime Ando; Ayako Hino; Tomohisa Nagata; Seiichiro Tateishi; Mayumi Tsuji; Shinya Matsuda; Yoshihisa Fujino
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

9.  Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.

Authors:  Galit Alter; Matthew Gorman; Nita Patel; Mimi Guebre-Xabier; Alex Zhu; Caroline Atyeo; Krista Pullen; Carolin Loos; Yenny Goez-Gazi; Ricardo Carrion; Jing-Hui Tian; Dansu Yuan; Kathryn Bowman; Bin Zhou; Sonia Maciejewski; Marisa McGrath; James Logue; Matthew Frieman; David Montefiori; Sharon Schendel; Erica Ollmann Saphire; Douglas Lauffenburger; Ann Greene; Alyse Portnoff; Michael Massare; Larry Ellingsworth; Gregory Glenn; Gale Smith; Colin Mann; Fatima Amanat; Florian Krammer
Journal:  Res Sq       Date:  2021-02-15

Review 10.  Diagnosis of COVID-19 in symptomatic patients: An updated review.

Authors:  M N Zahan; H Habibi; A Pencil; J Abdul-Ghafar; S A Ahmadi; N S Juyena; M T Rahman; M S Parvej
Journal:  Vacunas       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.